Disc Medicine Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company’s preclinical programs include DISC-0998.
/ 
Frequently asked questions
To buy Disc Medicine Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Disc Medicine Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Disc Medicine Inc. is IRON:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Disc Medicine Inc. has its primary listing on NASDAQ. You can trade Disc Medicine Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Disc Medicine Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Disc Medicine Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Disc Medicine Inc..